Physician profile
Thomas Kim
NPI 1144225301
$46,509.05
in general payments reported to CMS, 2019-2025
39 companies · $8,950 in 2025
The $8,950 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,042 · 2020: $1,004 · 2021: $2,569 · 2022: $2,841 · 2023: $9,031 · 2024: $16K · 2025: $8,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $11K · Travel and Lodging: $8,292 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Grant: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,643.81 |
| Consulting Fee | $10,922.50 |
| Travel and Lodging | $8,291.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Grant | $195.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,252.79 | 2019-2025 | Cardiomems, Mitraclip, Assurity |
| Edwards Lifesciences Corporation | $12,642.63 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Medtronic, INC. | $8,919.41 | 2021-2025 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $1,877.35 | 2019-2025 | |
| Medtronic Vascular, INC. | $1,575.87 | 2019 | |
| Boston Scientific Corporation | $858.91 | 2019-2025 | Watchman Flx, General - Structural Heart |
| Amgen INC. | $831.95 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $665.14 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $414.53 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $391.51 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $388.14 | 2019-2025 | Jardiance |
| Cvrx, INC. | $343.34 | 2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $332.63 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $323.54 | 2022-2025 | Optimizer, Optimizer |
| Sanofi-Aventis U.S. LLC | $316.78 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $316.22 | 2025 | |
| Cathworks, INC. | $283.14 | 2019 | |
| Chiesi USA, INC. | $248.32 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $239.72 | 2019-2025 | Farxiga, Wainua |
| Scpharmaceuticals INC. | $214.46 | 2023-2025 | |
| Cardiovascular Systems INC. | $175.60 | 2020-2022 | |
| Bridgebio Pharma, INC. | $133.06 | 2025 | Attruby |
| Shockwave Medical, INC | $126.04 | 2025 | |
| Alnylam Pharmaceuticals INC. | $94.39 | 2022-2023 | Amvuttra |
| Cardiva Medical, INC. | $81.07 | 2022-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $71.11 | 2022-2023 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $69.80 | 2022-2023 | Arcalyst |
| Astellas Pharma US INC | $57.16 | 2020-2021 | |
| Irhythm Technologies, INC. | $48.08 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $33.16 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $30.23 | 2025 | Winrevair |
| Ethicon US, LLC | $28.48 | 2025 | Vistaseal |
| Gilead Sciences, INC. | $23.23 | 2019 | |
| Portola Pharmaceuticals, LLC | $21.48 | 2019 | |
| Siemens Medical Solutions USA, INC. | $20.06 | 2020 | |
| Heartflow, INC. | $18.90 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.72 | 2021 | |
| Esperion Therapeutics, INC. | $13.17 | 2021 | |
| Atricure, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.